1. Home
  2. RLYB vs CASI Comparison

RLYB vs CASI Comparison

Compare RLYB & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • CASI
  • Stock Information
  • Founded
  • RLYB 2018
  • CASI 1991
  • Country
  • RLYB United States
  • CASI China
  • Employees
  • RLYB N/A
  • CASI N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RLYB Health Care
  • CASI Health Care
  • Exchange
  • RLYB Nasdaq
  • CASI Nasdaq
  • Market Cap
  • RLYB 24.1M
  • CASI 24.9M
  • IPO Year
  • RLYB 2021
  • CASI 1996
  • Fundamental
  • Price
  • RLYB $0.61
  • CASI $1.67
  • Analyst Decision
  • RLYB Hold
  • CASI Strong Buy
  • Analyst Count
  • RLYB 2
  • CASI 1
  • Target Price
  • RLYB N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • RLYB 290.8K
  • CASI 207.2K
  • Earning Date
  • RLYB 11-07-2025
  • CASI 11-13-2025
  • Dividend Yield
  • RLYB N/A
  • CASI N/A
  • EPS Growth
  • RLYB N/A
  • CASI N/A
  • EPS
  • RLYB N/A
  • CASI N/A
  • Revenue
  • RLYB $761,000.00
  • CASI $31,564,000.00
  • Revenue This Year
  • RLYB N/A
  • CASI N/A
  • Revenue Next Year
  • RLYB N/A
  • CASI N/A
  • P/E Ratio
  • RLYB N/A
  • CASI N/A
  • Revenue Growth
  • RLYB 154.51
  • CASI 36.64
  • 52 Week Low
  • RLYB $0.22
  • CASI $1.09
  • 52 Week High
  • RLYB $1.24
  • CASI $6.50
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 61.83
  • CASI 43.61
  • Support Level
  • RLYB $0.54
  • CASI $1.60
  • Resistance Level
  • RLYB $0.57
  • CASI $1.89
  • Average True Range (ATR)
  • RLYB 0.04
  • CASI 0.15
  • MACD
  • RLYB 0.01
  • CASI -0.02
  • Stochastic Oscillator
  • RLYB 93.92
  • CASI 12.26

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: